Cited by 260Protein Structure and DynamicsReceptor Mechanisms and SignalingHemoglobin structure and function

Controlling Allosteric Networks in Proteins

Dokholyan, Nikolay V.·2016·Chemical Reviews

Abstract

Allosteric transition, defined as conformational changes induced by ligand binding, is one of the fundamental properties of proteins. Allostery has been observed and characterized in many proteins, and has been recently utilized to control protein function via regulation of protein activity. Here, we review the physical and evolutionary origin of protein allostery, as well as its importance to protein regulation, drug discovery, and biological processes in living systems. We describe recently developed approaches to identify allosteric pathways, connected sets of pairwise interactions that are responsible for propagation of conformational change from the ligand-binding site to a distal functional site. We then present experimental and computational protein engineering approaches for control of protein function by modulation of allosteric sites. As an example of application of these approaches, we describe a synergistic computational and experimental approach to rescue the cystic-fibrosis-associated protein cystic fibrosis transmembrane conductance regulator, which upon deletion of a single residue misfolds and causes disease. This example demonstrates the power of allosteric manipulation in proteins to both elucidate mechanisms of molecular function and to develop therapeutic strategies that rescue those functions. Allosteric control of proteins provides a tool to shine a light on the complex cascades of cellular processes and facilitate unprecedented interrogation of biological systems.

Integrity signals

Registry

Crossref · 10.1021/acs.chemrev.5b00544

Cites

333 of 333 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DNA alkylation drugs, as the first class of drugs targeting DNA, have been clinically used for nearly 70 years to treat cancers.

    “DNA alkylation drugs, as the first class of drugs targeting DNA, have been clinically used for nearly 70 years to treat cancers.468”
  • The ensemble model of allostery holds that the allosteric behavior of a macromolecular system arises from the properties of the native free-energy landscape and how this landscape is remodeled by perturbations such as ligand binding, protonation, or interactions with other proteins.

    “According to the ensemble model, first described in the 1980s (Cooper, 1984; Frauenfelder et al., 1988), the allosteric behavior of a macromolecular system arises from the properties of the native free-energy landscape of the system, and how this land-scape is remodeled by various “perturbations,” such as ligand binding, protonation, or interactions with other proteins (Dokholyan, 2016; Kern and Z”

    From Allostery in Its Many Disguises: From Theory to Applications (2019) · cites this paper as Dokholyan, 2016

  • Unraveling the mechanistic underpinning of allosteric behavior in signaling should lead to improved understanding of how signaling events are relayed and regulated, and enable their modulation with promising pharmaceutical avenues for targeting human disease.

    “Unraveling the mechanistic underpinning of this behavior should therefore lead to improved understanding of how signaling events are relayed and regulated, and enable their modulation with promising pharmaceutical avenues for targeting human disease (Dokholyan, 2016).”

    From Allostery in Its Many Disguises: From Theory to Applications (2019) · cites this paper as Dokholyan, 2016

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dokholyan, N. V.
Affiliations
University of North Carolina at Chapel Hill (US)
Corresponding author
Dokholyan, Nikolay V.
Venue
Chemical Reviews
Published
2016-02-19
Volume
116
Issue
11
Pages
6463-6487
ISSN
  • 0009-2665 (ISSN-L)
  • 1520-6890
OpenAlex
W2283716387
Cited by
260
References
333
Citations by year
2026: 11 · 2025: 21 · 2024: 24 · 2023: 48 · 2022: 23 · 2021: 31 · 2020: 27 · 2019: 28 · 2018: 21 · 2017: 18 · 2016: 7
FWCI
2.23
Type
journal article
Language
en
Open access
closed
Locations
  • Chemical Reviews (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Allergy and Infectious Diseases (R01 AI102732)
  • National Institute of General Medical Sciences (5 R01 GM080742)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hemoglobin structure and function
Keywords
protein allostery, allosteric networks, allosteric pathways, ligand-induced conformational change, protein regulation, protein engineering, cystic fibrosis transmembrane conductance regulator, CFTR, protein misfolding, drug discovery
MeSH terms
Allosteric Regulation, Allosteric Site, Humans, Ligands, Proteins, Cystic Fibrosis Transmembrane Conductance Regulator, Protein Structure, Quaternary, Focal Adhesion Protein-Tyrosine Kinases, Molecular Dynamics Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review